Without transparent and accountable health systems, patients are less able to take the proactive role that is needed for patient-centred care to be achieved. National procurement and drug pricing systems that lack robust monitoring mechanisms can become open to corruption and exploitation, posing a...
Patient information is one of the pillars of the IAPO Declaration of patient-centred healthcare. It represents a primary vehicle for patient advocates to better engage in and contribute to healthcare more effectively. For this to happen, however, it is crucial that patients play an active role in the information process.
You know your meeting is going to make a difference globally when two of the most powerful medical regulators turn up at your event. IAPO member, Consumer Online Foundation , pulled off this feat when it hosted a two day International Forum on Patient Safety and Safe Access to Online Pharmacies in...
Contributed by Thong Meow-Keong, Malaysian Rare Disorders Society (IAPO member) Rare diseases particularly birth defects are a major causes of disability in developing countries (1,2). There is lack of data on birth defects from large population-based studies in the Asia-Pacific region (3). The...
On 1 March 2017, Active Citizenship Network is going to celebrate the first anniversary of its EU communication campaign on cross-border healthcare. Foreseen by Directive 2011/24/EU – it’s named Patients’ rights have no borders – with a multi stakeholder conference at the EU Parliament. The...
On 15 February 2016, the Anti-counterfeit Network Africa was launched in Uganda to help in intensifying the fight against production & supply of Counterfeit drugs to ensure patient access to quality medicine. According to WHO, Substandard, spurious, falsely labelled, falsified and counterfeit (...
IAPO’s 2017 member engagement and empowerment plan will be centred on four main thematic areas: Patient-centred healthcare, Access, Accountability and Transparency, and the Patient Solidarity Day theme (to be decided by our members in the forthcoming months). This policy document kicks off our...
Sophie Andersson, Executive Director of the International Federation of Psoriasis Associations (IFPA), returns to the World Health Organization’s 140th Executive Board Session this year where in 2014 IFPA got through a historic resolution recognizing psoriasis as a non-communicable disease and...
The International Prevention Research Institute (iPRI) President Professor Peter Boyle signed an important Memorandum of Understanding with our Chair of the Board Jolanta Bilińska to mark the World Cancer Day. The role of patients’ organizations is morphing rapidly from its initial lobbying focus...

Pages